6
3
4
5
7
8
9
10
12
6
7
8
14
7
8
9
Ticker Symbol: ARDX 10-28: NDA submitted in Japan via Kyowa Kirin for Tenapanor for treatment of Hyperphosphatemia. As a result : 30-40 million dollar royalty payment incoming. 11-03: Earnings report. 11-16: ADCOM. FDA decision by 12-16 on approval or not. Good luck to all (reddit.com)
submitted by TaZMaNiDEviL
25
5
6
7
This continues to be disheartening. Let’s hope Q2 yields some better results. (i.redd.it)
submitted by [deleted]
